Skip to main content
OpenTrials
Completed

NCT Number: NCT06537687

Relational Agents in Cervical Cancer Education (RACE)

The goal of this clinical trial is to assess the feasibility of using interactive teaching to educate cervical cancer patients about Human papillomavirus (HPV) and HPV vaccinations.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cervix Cancer Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Genital Diseases Genital Diseases, Female Genital Neoplasms, Female Human Papilloma Virus Neoplasms Neoplasms by Site Urogenital Diseases Urogenital Neoplasms Uterine Cervical Diseases Uterine Cervical Neoplasms Uterine Diseases Uterine Neoplasms Vaginal Cancer Vaginal Diseases Vaginal Neoplasms Vulvar Cancer Vulvar Diseases Vulvar Neoplasms

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Karmanos Cancer Institute, Detroit, Michigan, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults aged 18 and older
  • Patients with an ICD9 diagnosis of cervical/vaginal/vulvar cancer or dysplasia receiving care at Karmanos Cancer Institute or OU Health Stephenson Cancer Center

Exclusion criteria

  • Patients who are recorded in the EHR as requesting to be removed from research
  • Non-English speakers
  • Any cognitive disability that prevents informed consent
  • Any individual recruited in previous phases of the Study will be excluded.

Treatment and study plan

Control

Other

A standardized handout on HPV and vaccine education will be given

Intervention

Other

A video about HPV and vaccines on a tablet provided by a research assistant

Primary outcomes

  1. Participation Rate

    Time frame: Up to 6 weeks

    The Ratio of the number of participants to the number of patients asked to join the clinical trial

  2. Survey Completion Rate

    Time frame: Up to 6 Weeks

    The Ratio of the number of participants who complete the survey to the number of participants overall.

Secondary outcomes

  1. Change in intention to discuss HPV vaccination

    Time frame: Up to 6 weeks

    Changes from pre to post/follow up on intervention survey

  2. Change in Health Literacy

    Time frame: Up to 6 weeks

    Changes in knowledge of HPV virus and prevention from pre to post/follow up survey

  3. Change in social norms and behaviors

    Time frame: Up to 6 weeks

    Changes in social norms and behavioral control measures from pre and post/follow-up survey

  4. Change in Stigma

    Time frame: Up to 6 weeks

    Changes in stigma measures in pre and post/follow up surveys

Sponsors and collaborators

Lead sponsor

Radhika Gogoi

Other

Collaborators

  • University of Oklahoma

Registry information

Acronym: RACE

Important dates

Study start
2020
Primary completion
2023
Study completion
2023
First posted
Aug 5, 2024
Registry last updated
Aug 5, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.